Replies to post #179 on iRobot Corporation (IRBT)

[faxedreceipts]

IRBT, for now, has an official monopoly to sell medical robots to the
healthcare industry with the FDA's blessing. The market for these robots is going to grow substantially as doctor shortages have become prominent in this new medical era of lower medicare/medicaid payments to doctors, increasing liability costs, ever increasing regulaions. IRBT will hit a home run with their doctor IBOT.

Their entrance into robotic manufacturing with 3D printing wil put IRBT into this impressive new era of growth and change manufacturing in ways we can't imagine. Let's just say that once throbot is implemented, humans are going to have a lot less job opportunities in manufacturing.

IRBT has huge potential and is way undervalued at 23 and change.